Home > Cashflow Statement > INDOCO REMEDIES

INDOCO REMEDIES
Cashflow Statement

INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
AD     Remove this Ad

INDOCO REMEDIES Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹-75 Cr₹124 Cr₹193 Cr₹237 Cr₹132 Cr
Adjustment ₹184 Cr₹138 Cr₹121 Cr₹87 Cr₹110 Cr
Changes In working Capital ₹2.78 Cr₹-88 Cr₹-73 Cr₹-109 Cr₹-140 Cr
Cash Flow after changes in Working Capital ₹111 Cr₹173 Cr₹240 Cr₹215 Cr₹102 Cr
Cash Flow from Operating Activities ₹95 Cr₹155 Cr₹179 Cr₹174 Cr₹82 Cr
Cash Flow from Investing Activities ₹-339 Cr₹-433 Cr₹-208 Cr₹-121 Cr₹-67 Cr
Cash Flow from Financing Activities ₹241 Cr₹280 Cr₹23 Cr₹-44 Cr₹-30 Cr
Net Cash Inflow / Outflow ₹-2.76 Cr₹3.31 Cr₹-6.54 Cr₹8.05 Cr₹-14 Cr
Opening Cash & Cash Equivalents ₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr₹24 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -₹0.62 Cr---
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹12 Cr₹15 Cr₹11 Cr₹17 Cr₹9.42 Cr

Compare Cashflow Statement of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹1,707.1 Cr -4.7% -6.9% -20.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,555.0 Cr -1.5% 1.6% 1.3% Stock Analytics
DIVIS LABORATORIES ₹159,889.0 Cr -2% -4.3% 3.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,073.0 Cr -0.8% 0.5% 32% Stock Analytics
DR REDDYS LABORATORIES ₹105,133.0 Cr -2.7% -1.6% 6.9% Stock Analytics
CIPLA ₹98,492.9 Cr -3.9% -9.1% -18.4% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

-4.7%

-6.9%

-20.9%

SENSEX

-2.6%

-10.2%

-1.6%


You may also like the below Video Courses